Nitisinone (LogixX Pharma) Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

nitisinone (logixx pharma)

te arai biofarma limited - nitisinone 2mg - capsule - 2 mg - active: nitisinone 2mg excipient: gelatin starch stearic acid titanium dioxide - indicated for the treatment of adult and paediatric (in any age range) patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht-1) in combination with dietary restriction of tyrosine and phenylalanine.

Nitisinone (LogixX Pharma) Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

nitisinone (logixx pharma)

te arai biofarma limited - nitisinone 5mg - capsule - 5 mg - active: nitisinone 5mg excipient: gelatin starch stearic acid titanium dioxide - indicated for the treatment of adult and paediatric (in any age range) patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht-1) in combination with dietary restriction of tyrosine and phenylalanine.

NITYR ( NITISINONE) 10 MG Israel - engelska - Ministry of Health

nityr ( nitisinone) 10 mg

truemed ltd, israel - nitisinone - tablets - nitisinone 10 mg - nitisinone - treatment of patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht-1) in combination with dietary restriction of tyrosine and phenylalanine.

NITYR ( NITISINONE) 2 MG Israel - engelska - Ministry of Health

nityr ( nitisinone) 2 mg

truemed ltd, israel - nitisinone - tablets - nitisinone 2 mg - nitisinone - treatment of patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht-1) in combination with dietary restriction of tyrosine and phenylalanine.

NITYR ( NITISINONE) 5 MG Israel - engelska - Ministry of Health

nityr ( nitisinone) 5 mg

truemed ltd, israel - nitisinone - tablets - nitisinone 5 mg - nitisinone - treatment of patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht-1) in combination with dietary restriction of tyrosine and phenylalanine.

NITYR nitisinone 5 mg tablet bottle Australien - engelska - Department of Health (Therapeutic Goods Administration)

nityr nitisinone 5 mg tablet bottle

orpharma pty ltd - nitisinone, quantity: 5 mg - tablet - excipient ingredients: lactose monohydrate; glycerol dibehenate - nityr tablets (nitisinone) are indicated for the treatment of patients with hereditary tyrosinaemia type 1 in combination with dietary restriction of tyrosine and phenylalanine.

NITYR nitisinone 2 mg tablet bottle Australien - engelska - Department of Health (Therapeutic Goods Administration)

nityr nitisinone 2 mg tablet bottle

orpharma pty ltd - nitisinone, quantity: 2 mg - tablet - excipient ingredients: lactose monohydrate; glycerol dibehenate - nityr tablets (nitisinone) are indicated for the treatment of patients with hereditary tyrosinaemia type 1 in combination with dietary restriction of tyrosine and phenylalanine.

NITYR nitisinone 10 mg tablet bottle Australien - engelska - Department of Health (Therapeutic Goods Administration)

nityr nitisinone 10 mg tablet bottle

orpharma pty ltd - nitisinone, quantity: 10 mg - tablet - excipient ingredients: lactose monohydrate; glycerol dibehenate - nityr tablets (nitisinone) are indicated for the treatment of patients with hereditary tyrosinaemia type 1 in combination with dietary restriction of tyrosine and phenylalanine.

Nitisinone Dipharma 5 mg hard caps. Belgien - engelska - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

nitisinone dipharma 5 mg hard caps.

dipharma arzneimittel gmbh - nitisinone 5 mg - capsule, hard - 5 mg - nitisinone 5 mg - nitisinone

Nitisinone Dipharma 10 mg hard caps. Belgien - engelska - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

nitisinone dipharma 10 mg hard caps.

dipharma arzneimittel gmbh - nitisinone 10 mg - capsule, hard - 10 mg - nitisinone 10 mg - nitisinone